Abstract

PHP110 Real-World Diagnosis and Treatment Patterns of Iron Deficiency Anemia in China

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Abstract P2-16-33: Patient characteristics and real-world treatment patterns in patients with early-stage triple-negative breast cancer receiving neoadjuvant chemotherapy
Whitney C Rhodes ... Min Huang
American Journal of Cancer | VOL. 80
Whitney C Rhodes, et. al.Whitney C Rhodes ... Min Huang
14 Feb 2020
The Prevalence and Risk Factors for Maternal Anemia and Iron Deficiency Anemia in China (P11-042-19)
Jiang Shan ... Bi Ye
Current developments in nutrition | VOL. 3
Jiang Shan, et. al.Jiang Shan ... Bi Ye
01 Jun 2019
Abstract PO2-17-06: Real world treatment patterns and clinical outcomes by germline BRCA (gBRCA) mutation status in patients with HER2-negative early breast cancer in the US community oncology setting: a retrospective observational chart-review study
Jay Andersen ... Nicole Fulcher
American Journal of Cancer | VOL. 84
Jay Andersen, et. al.Jay Andersen ... Nicole Fulcher
02 May 2024
Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose
Shanlian Hu ... Yabing Zhang
Journal of Medical Economics | VOL. 25
Shanlian Hu, et. al.Shanlian Hu ... Yabing Zhang
04 May 2022
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers